81 related articles for article (PubMed ID: 10542106)
1. 32P-postlabeling assay for the quantification of the major platinum-DNA adducts.
Pluim D; Maliepaard M; van Waardenburg RC; Beijnen JH; Schellens JH
Anal Biochem; 1999 Nov; 275(1):30-8. PubMed ID: 10542106
[TBL] [Abstract][Full Text] [Related]
2. Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.
Welters MJ; Maliepaard M; Jacobs-Bergmans AJ; Baan RA; Schellens JH; Ma J; van der Vijgh WJ; Braakhuis BJ; Fichtinger-Schepman AM
Carcinogenesis; 1997 Sep; 18(9):1767-74. PubMed ID: 9328174
[TBL] [Abstract][Full Text] [Related]
3. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
[TBL] [Abstract][Full Text] [Related]
4. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
Shibutani S; Kim SY; Suzuki N
Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
[TBL] [Abstract][Full Text] [Related]
5. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
Gorelick NJ; Wogan GN
Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
[TBL] [Abstract][Full Text] [Related]
6. Detection of platinum-DNA adducts by 32P-postlabelling.
Blommaert FA; Saris CP
Nucleic Acids Res; 1995 Apr; 23(8):1300-6. PubMed ID: 7753620
[TBL] [Abstract][Full Text] [Related]
7. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
8. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
Kovács K; Anna L; Rudnai P; Schoket B
Mutat Res; 2011 Mar; 721(1):95-100. PubMed ID: 21237286
[TBL] [Abstract][Full Text] [Related]
9. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.
Fichtinger-Schepman AM; van der Velde-Visser SD; van Dijk-Knijnenburg HC; van Oosterom AT; Baan RA; Berends F
Cancer Res; 1990 Dec; 50(24):7887-94. PubMed ID: 2253228
[TBL] [Abstract][Full Text] [Related]
11. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
[TBL] [Abstract][Full Text] [Related]
12. Accurate and sensitive quantitation of N7-methyldeoxyguanosine-3'-monophosphate by 32P-postlabeling and storage-phosphor imaging.
Haque K; Cooper DP; van Delft JH; Lee SM; Povey AC
Chem Res Toxicol; 1997 Jun; 10(6):660-6. PubMed ID: 9208172
[TBL] [Abstract][Full Text] [Related]
13. The 32P-postlabeling assay for DNA adducts.
Phillips DH; Arlt VM
Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
[TBL] [Abstract][Full Text] [Related]
14. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
16. 7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay.
Kato S; Petruzzelli S; Bowman ED; Turteltaub KW; Blomeke B; Weston A; Shields PG
Carcinogenesis; 1993 Apr; 14(4):545-50. PubMed ID: 8386066
[TBL] [Abstract][Full Text] [Related]
17. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
Johnsson A; Olsson C; Nygren O; Nilsson M; Seiving B; Cavallin-Stahl E
Cancer Chemother Pharmacol; 1995; 37(1-2):23-31. PubMed ID: 7497593
[TBL] [Abstract][Full Text] [Related]
20. In vivo detection of DNA adducts induced by cisplatin using capillary HPLC-ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster.
García Sar D; Montes-Bayón M; Aguado Ortiz L; Blanco-González E; Sierra LM; Sanz-Medel A
Anal Bioanal Chem; 2008 Jan; 390(1):37-44. PubMed ID: 17932658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
